Abstract:Background: More than 60% of the new drug molecules are lipophilic in nature. Low aqueous solubility and thus poor bioavailability is the main issue for these drugs for successful formulations into oral dosage form. Self-microemulsifying drug delivery systems (SMEDDS) have gained much attention. These are isotropic mixtures of different components (oil, surfactant and cosurfactant) that quickly disperse in gastrointestinal fluid yielding micro/nano-emulsions. These systems contain solubilized drug that is absorbed by lymphatic pathway along with other pathways like diffusion, collisional transfer, intracellular junctions, biliary acid pathway (BA), biliary acid mixed micelles pathway (BAMM) etc. and thus hepatic first pass metabolism is reduced. Stability of conventional SEDDS is considered very high with reference to other drug delivery systems as liposome, nanoparticles, nanoemulsion and micro emulsion. In fact SEDDS does not contain water in their composition which enhances their chemical and physical stability. Very few works have studied the stability of conventional SEDDS as it was confirmed. The major drawback for conventional SEDDS could be- i) high manufacturing cost (as they have to be filled in soft gelatin capsules); ii) interaction of capsule shell components with SEDDS. Therefore, attention has been given to transform liquid into solid SMEDDS by several techniques such as spray drying, spray cooling, super critical fluid technology and using adsorption carriers. Adsorption using solid carriers (Neusilin, Fujicalin, and dextran) is the successful inexpensive technique at initial research level whereas other requires expensive instrumentation. Conclusion: Current review focuses on biopharmaceutical aspects, characterization of SMEDDS and excipients used in the formulation, techniques used for conversion of liquid SMEDDS to solid SMEDDS (including examples of various research reports where these techniques are used). Various adsorbent carriers (alongwith their different features) which have been reported in research papers have been detailed. It thoroughly covers patent literature on SMEDDS and research carried on solid SMEDDS as well which is the most imperative part of the review.

Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance

Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs

Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Emerging Lipid Based Drug Delivery Systems

Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development

Prospectives of Solid Self-microemulsifying Systems in Novel Drug Delivery

SOLUBILITY ENHANCEMENT BY SOLID DISPERSION METHOD: A REVIEW

Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective

Tableting lipid-based formulations for oral drug delivery: a case study with silica nanoparticle-lipid-mannitol hybrid microparticles

Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery

Solid lipid nanocarriers as alternative drug delivery system for improved oral delivery of drugs

The State of Water and Its Impact on Pharmaceutical Systems: Lipid-Based Drug Delivery Systems and Amorphous Solids

A Review on Formulation and Development of Solid Self-Nano Emulsifying Drug Delivery Systems

Lipid-Based Nanoparticles as Oral Drug Delivery Systems: Overcoming Poor Gastrointestinal Absorption and Enhancing Bioavailability of Peptide and Protein Therapeutics

Lipid-Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs

A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

Solid dispersion of poorly water‐soluble drugs: Early promises, subsequent problems, and recent breakthroughs

Carrier Systems for Advanced Drug Delivery: Improving Drug Solubility/Bioavailability and Administration Routes

Adapting Liposomes for Oral Drug Delivery

Recent Advances in the Preparation, Properties, and Applications of Solid Lipid Nanoparticles in Drug Delivery

Nanostructured lipid carriers: A platform to lipophilic drug for oral bioavailability enhancement

Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery